News
Nutritional counseling remains a central component of obesity treatment, even in the era of highly effective weight-loss ...
Pedersen and Maggie Fick COPENHAGEN/LONDON (Reuters) -Obesity drugmaker Novo Nordisk downgraded its 2025 sales forecast on ...
COPENHAGEN (Reuters) -Obesity drugmaker Novo Nordisk on Wednesday cut its full-year sales and profit outlook amid lacklustre ...
Nationally representative survey data revealed that glucagon-like peptide 1 receptor agonists (GLP-1 RAs) use for obesity ...
3d
MedPage Today on MSNWegovy Pill Under Review; FDA Lifts Obesity Trial Clinical Hold; SGLT2s and SurgeryThe FDA will decide whether to approve a once-daily, 25 mg oral formulation of semaglutide (Wegovy) by the end of 2025. If ...
Wegovy has been approved by Health Canada for some children aged 12 and up with obesity. Ozempic has not been approved for ...
33m
News Medical on MSNStudy reveals colonic inflammation as the trigger for beta cell growth in obesityResearchers at the Tohoku University Graduate School of Medicine have uncovered a key primary step in the hepatic ERK pathway that leads to increased insulin production.
Researchers at the Tohoku University Graduate School of Medicine have uncovered a key primary step in the hepatic ERK pathway ...
"An exciting finding was when we tried to treat the obese mice with colon inflammation by lowering their inflammation, it actually stopped the ERK pathway in the liver from activating," explains Imai.
The event will take place from June 19 to 22 at La Hacienda Links Golf Resort and the Fairmont La Hacienda Costa del Sol ...
A study was conducted to determine the clinical efficacy of GLP-1RAs for secondary prevention of atrial fibrillation and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results